BeStock  
Stocks › Biotechnology › SMMT

Summit Therapeutics SMMT

US equityMarket cap rank #1601BiotechnologyTop Gainers Yesterday
$9.95 −$0.62 (-5.87%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $10.08 +1.31%
Open$10.28
Prev close$10.57
Day range$9.89 – $10.61
Volume7.22M
Market cap$7.96B
P/E (TTM)–
Dividend yield–

SMMT Stock News

Headlines matching Summit Therapeutics or the SMMT ticker, most recent first.

  • Jefferies Upgrades Summit Therapeutics(SMMT.US) to Buy Rating, Raises Target Price to $25 PositiveMarket news · 9 Sep 2026 · Direct mention
  • A Quick Look at Today's Ratings for Summit Therapeutics(SMMT.US), With a Forecast Between $16 to $43Market news · 30 Sep 2026 · Direct mention
  • Clear Street Initiates Summit Therapeutics(SMMT.US) With Buy Rating, Announces Target Price $31Market news · 3 Sep 2026 · Direct mention
  • H.C. Wainwright Maintains Summit Therapeutics(SMMT.US) With Hold RatingMarket news · 23 Sep 2026 · Direct mention
  • Barclays Maintains Summit Therapeutics(SMMT.US) With Hold Rating, Maintains Target Price $18Market news · 21 Sep 2026 · Direct mention
  • UBS Maintains Summit Therapeutics(SMMT.US) With Buy Rating, Maintains Target Price $33Market news · 14 Sep 2026 · Direct mention
  • Citi Maintains Summit Therapeutics(SMMT.US) With Buy Rating, Maintains Target Price $40Market news · 14 Sep 2026 · Direct mention
  • Goldman Sachs Maintains Summit Therapeutics(SMMT.US) With Buy Rating, Maintains Target Price $41Market news · 14 Sep 2026 · Direct mention
  • Wells Fargo Maintains Summit Therapeutics(SMMT.US) With Buy Rating, Maintains Target Price $30Market news · 27 Aug 2026 · Direct mention
  • Wolfe Research Initiates Summit Therapeutics(SMMT.US) With Hold RatingMarket news · 17 Aug 2026 · Direct mention
  • Bernstein Maintains Summit Therapeutics(SMMT.US) With Sell Rating, Maintains Target Price $9.8Market news · 11 Aug 2026 · Direct mention
  • Stifel Maintains Summit Therapeutics(SMMT.US) With Buy Rating, Maintains Target Price $38Market news · 29 Jul 2026 · Direct mention
  • TD Cowen Maintains Summit Therapeutics(SMMT.US) With Buy RatingMarket news · 28 Jul 2026 · Direct mention
  • A Quick Look at Today's Ratings for Summit Therapeutics(SMMT.US), With a Forecast Between $15 to $40Market news · 25 Jul 2026 · Direct mention
  • A Quick Look at Today's Ratings for Summit Therapeutics(SMMT.US), With a Forecast Between $16 to $40Market news · 24 Jul 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on SMMT.

Sign in to join the discussion.

Scroll to Top